Intro

This chapter explores the latest movements in the biotech sector, particularly Starboard's activist campaign against Pfizer. It also delves into the challenges of Duchenne therapy assessments, Robert F. Kennedy Jr.'s health initiative, and Regeneron's innovative responses to modern clinical trial complexities.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app